We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

"Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Scranton-Temple Residency Program.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00984685
First Posted: September 25, 2009
Last Update Posted: September 25, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Scranton-Temple Residency Program
  Purpose
The purpose of the study is to identify the barriers for effective treatment of depression, specifically whether modified CHIS Scale is a valid tool for identifying the high risk patients for depression.

Condition
Depression

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: "Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"

Further study details as provided by Scranton-Temple Residency Program:

Primary Outcome Measures:
  • proportion of anti-depressant prescriptions filled [ Time Frame: August 1, 2008 through July 31, 2009 ]

Estimated Enrollment: 100
Study Start Date: August 2009
Estimated Study Completion Date: October 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
depression
Patients diagnosed with depression before April 15, 2009

Detailed Description:

Depression is a major illness that affects 10% of the population in a medical setting. It is often under diagnosed and under treated. It is an illness that can challenge a persons ability to perform even routine daily activities. Review of the charts of patients diagnosed with depression showed 80% of the patients do not have follow up appointments. We wondered if modified CHIS scale could identify the risk factors for medication non-adherence.

We hypothesised that modified CHIS Scale an effective tool ,for identifying the compliance of patients with the antidepressant medication.

We are conducting a retrospective cohort study at two of our residency based clinics by interviewing approximately 100 patients with CHIS Scale and PHQ9 Questionnaire on their office visits

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with the diagnosis of depression in theprimary care clinic
Criteria

Inclusion Criteria:

  • Diagnosis of depression before April 15, 2009
  • At least one visit since April 15, 2008
  • Age 18+

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00984685


Locations
United States, Pennsylvania
Scranton Temple Residency Program Recruiting
Scranton, Pennsylvania, United States, 18510
Contact: John R Guzek, MD    570-357-7731    guzekj@strpweb.org   
Principal Investigator: John R Guzek, MD         
Sub-Investigator: Srividhya R Lakshmanan, MD         
Sponsors and Collaborators
Scranton-Temple Residency Program
Investigators
Principal Investigator: John R Guzek, MD Scranton-Temple Residency Program
  More Information

Responsible Party: Dr. John R Guzek MD, Scranton-Temple Residency Program
ClinicalTrials.gov Identifier: NCT00984685     History of Changes
Other Study ID Numbers: STRP0002
First Submitted: September 24, 2009
First Posted: September 25, 2009
Last Update Posted: September 25, 2009
Last Verified: September 2009

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders